These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 38999044)
1. Tailoring Fibroblast-Activation Protein Targeting for Theranostics: A Comparative Preclinical Evaluation of the Läppchen T; Bilinska A; Pilatis E; Menéndez E; Imlimthan S; Moon ES; Afshar-Oromieh A; Rösch F; Rominger A; Gourni E Molecules; 2024 Jun; 29(13):. PubMed ID: 38999044 [TBL] [Abstract][Full Text] [Related]
2. Huang J; Zhang X; Liu Q; Gong F; Huang Y; Huang S; Fu L; Tang G J Med Chem; 2024 Oct; 67(19):17785-17795. PubMed ID: 39321030 [TBL] [Abstract][Full Text] [Related]
3. Targeting CXCR4/CXCL12 axis via [ Bao G; Wang Z; Liu L; Zhang B; Song S; Wang D; Cheng S; Moon ES; Roesch F; Zhao J; Yu B; Zhu X Eur J Nucl Med Mol Imaging; 2024 Jul; 51(9):2744-2757. PubMed ID: 38587644 [TBL] [Abstract][Full Text] [Related]
4. First-In-Human Results on the Biodistribution, Pharmacokinetics, and Dosimetry of [ Ballal S; Yadav MP; Moon ES; Kramer VS; Roesch F; Kumari S; Bal C Pharmaceuticals (Basel); 2021 Nov; 14(12):. PubMed ID: 34959613 [TBL] [Abstract][Full Text] [Related]
5. A radiohybrid theranostics ligand labeled with fluorine-18 and lutetium-177 for fibroblast activation protein-targeted imaging and radionuclide therapy. Yang T; Peng L; Qiu J; He X; Zhang D; Wu R; Liu J; Zhang X; Zha Z Eur J Nucl Med Mol Imaging; 2023 Jul; 50(8):2331-2341. PubMed ID: 36864362 [TBL] [Abstract][Full Text] [Related]
6. Development and Evaluation of DOTA-FAPI-Maleimide as a Novel Radiotracer for Tumor Theranostic with Extended Circulation. Feng L; Hu W; Zeng X; Wei Z; Long Y; Li M; Sun S; Guo Z; Lan X; Zhang X; Zhuang R; Jiang D Mol Pharm; 2024 Sep; 21(9):4386-4394. PubMed ID: 39046432 [TBL] [Abstract][Full Text] [Related]
7. Development of Fibroblast Activation Protein Inhibitor-Based Dimeric Radiotracers with Improved Tumor Retention and Antitumor Efficacy. Zhao L; Chen J; Pang Y; Fang J; Fu K; Meng L; Zhang X; Guo Z; Wu H; Sun L; Su G; Lin Q; Chen H Mol Pharm; 2022 Oct; 19(10):3640-3651. PubMed ID: 35917335 [TBL] [Abstract][Full Text] [Related]
8. Therapeutic potential of [ Yadav MP; Ballal S; Martin M; Roesch F; Satapathy S; Moon ES; Tripathi M; Gogia A; Bal C Eur J Nucl Med Mol Imaging; 2024 Feb; 51(3):805-819. PubMed ID: 37932560 [TBL] [Abstract][Full Text] [Related]
9. Development of FAPI Tetramers to Improve Tumor Uptake and Efficacy of FAPI Radioligand Therapy. Pang Y; Zhao L; Fang J; Chen J; Meng L; Sun L; Wu H; Guo Z; Lin Q; Chen H J Nucl Med; 2023 Sep; 64(9):1449-1455. PubMed ID: 37321827 [TBL] [Abstract][Full Text] [Related]
10. Fibroblast Activation Protein (FAP) targeting homodimeric FAP inhibitor radiotheranostics: a step to improve tumor uptake and retention time. Moon ES; Ballal S; Yadav MP; Bal C; Van Rymenant Y; Stephan S; Bracke A; Van der Veken P; De Meester I; Roesch F Am J Nucl Med Mol Imaging; 2021; 11(6):476-491. PubMed ID: 35003886 [TBL] [Abstract][Full Text] [Related]
11. In Vitro Evaluation of the Squaramide-Conjugated Fibroblast Activation Protein Inhibitor-Based Agents AAZTA Moon ES; Van Rymenant Y; Battan S; De Loose J; Bracke A; Van der Veken P; De Meester I; Rösch F Molecules; 2021 Jun; 26(12):. PubMed ID: 34201111 [TBL] [Abstract][Full Text] [Related]
12. [ Ballal S; Yadav MP; Raju S; Roesch F; Martin M; Tripathi M; Bal C Nucl Med Mol Imaging; 2024 Feb; 58(1):32-34. PubMed ID: 38261876 [TBL] [Abstract][Full Text] [Related]
13. Albumin Binder-Conjugated Fibroblast Activation Protein Inhibitor Radiopharmaceuticals for Cancer Therapy. Xu M; Zhang P; Ding J; Chen J; Huo L; Liu Z J Nucl Med; 2022 Jun; 63(6):952-958. PubMed ID: 34593598 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of Poly(ADP-ribose) Polymerase Sensitizes [ Bao G; Zhou H; Zou S; Chen L; Zhang B; Wang Z; Moon ES; Zhao J; Roesch F; Zhu X Mol Pharm; 2023 May; 20(5):2443-2451. PubMed ID: 37067162 [TBL] [Abstract][Full Text] [Related]
16. Targeting fibroblast activation protein (FAP): next generation PET radiotracers using squaramide coupled bifunctional DOTA and DATA Moon ES; Elvas F; Vliegen G; De Lombaerde S; Vangestel C; De Bruycker S; Bracke A; Eppard E; Greifenstein L; Klasen B; Kramer V; Staelens S; De Meester I; Van der Veken P; Rösch F EJNMMI Radiopharm Chem; 2020 Jul; 5(1):19. PubMed ID: 32728930 [TBL] [Abstract][Full Text] [Related]
17. Non-invasive visualization of liver fibrosis with [ Song Y; Qin C; Chen Y; Ruan W; Gai Y; Song W; Gao Y; Hu W; Qiao P; Song X; Lv X; Zheng D; Chu H; Jiang D; Yang L; Lan X Eur J Nucl Med Mol Imaging; 2024 Oct; 51(12):3572-3584. PubMed ID: 38850311 [TBL] [Abstract][Full Text] [Related]
18. Synthesis, Preclinical Evaluation, and a Pilot Clinical PET Imaging Study of Zhao L; Niu B; Fang J; Pang Y; Li S; Xie C; Sun L; Zhang X; Guo Z; Lin Q; Chen H J Nucl Med; 2022 Jun; 63(6):862-868. PubMed ID: 34556528 [TBL] [Abstract][Full Text] [Related]
20. Novel Generation of FAP Inhibitor-Based Homodimers for Improved Application in Radiotheranostics. Martin M; Ballal S; Yadav MP; Bal C; Van Rymenant Y; De Loose J; Verhulst E; De Meester I; Van Der Veken P; Roesch F Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980775 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]